Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep390 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Uricemia in hypertensive type 2 diabetics: the forgotten metabolic parameter

Haj Kacem Akid Faten , Frikha Hamdi , Chehaider Cyrine , Salah Ameni , Ben Salah Dhoha , Mnif Mouna , Charfi Nadia , Mnif Fatma , Rekik Majdoub Nabila , Elleuch Mouna , Abid Mohamed

Introduction: Hyperuricemia is a common metabolic feature in patients with metabolic syndrome.Aim: The aim of our work is to study the correlation between uric acid level and the metabolic profile in hypertensive type 2 diabetic patients.Methods: This is a retrospective descriptive study of hypertensive type 2 diabetic patients followed in the endocrinology department of Hedi Chaker University Hospital of Sfax, Tunisia between 2019...

ea0081ep392 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Diabetic foot: a tunisian experience

Elleuch Mouna , Frikha Hamdi , Ben Salah Dhoha , Mnif Fatma , Mnif Mouna , Charfi Nadia , Rekik Majdoub Nabila , Haj Kacem Akid Faten , Abid Mohamed

Introduction and aim: Diabetic foot (DF) is associated with increased morbimortality and cost of diabetes management. The aim of this study is to describe the epidemiological, clinical and paraclinical characteristics and follow-up outcomes of patients with diabetic foot in a Tunisian center.Methods: It is a monocentric retrospective study of 210 patients with diabetic foot followed at the endocrinology department of the Hedi Chaker Sfax University Hospi...

ea0081ep665 | Pituitary and Neuroendocrinology | ECE2022

Giant prolactinomas: a descriptive study and prognostic analysis

Elleuch Mouna , Frikha Hamdi , Fatma Loukil , Salah Dhoha Ben , Souhir Maalej , Mnif Mouna , Mnif Fatma , Charfi Nadia , Majdoub Nabila Rekik , Akid Faten Haj Kacem , Abid Mohamed

Introduction: Giant prolactinomas (GP), defined as prolactinomas ≥4 cm in maximum dimension, are uncommon, with reported prevalence of 2 to 3% of all prolactinomas. Aim: The aim of this study is to describe clinical and paraclinical characteristics of GP and to identify predictors of therapeutic response.Matherials and methods: A retrospective, single-center, descriptive study including 18 patients with GP followed at the end...

ea0081ep726 | Pituitary and Neuroendocrinology | ECE2022

Predictive factors of biological remission in patients with prolactinoma treated with dopamine agonists

Elleuch Mouna , Frikha Hamdi , Fatma Loukil , Salah Dhoha Ben , Souissi Matiem , Mnif Fatma , Mnif Mouna , Charfi Nadia , Majdoub Nabila Rekik , Akid Faten Haj Kacem , Abid Mohamed

Introduction and aim: Dopamine agonists (DA) are prescribed as first-line treatment for prolactinomas and are generally effective and well tolerated. However, the degree and quickness of therapeutic response is variable among patients. The aim of this work is to study the predictive factors of biological remission in patients with prolactinoma treated with DA. Methods: A single-center, retrospective and analytical study of patients with prolactinoma foll...

ea0090p64 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Covid-induced relapse of exogenous insulin autoimmune syndrome successfully treated with Rituximab and plasmapheresis

Frikha Hamdi , Mnif Mouna , Ben Salah Dhoha , Dhieb Nesrine , Elleuch Mouna , Mnif Fatma , REKIK Majdoub NABILA , Charfi Nadia , Haj Kacem Akid Faten , Abid Mohamed

Introduction: Exogenous insulin autoimmune syndrome (EIAS) is a rare cause of hypoglycemia in patients with diabetes treated with exogenous insulin. Flares of auto-immune diseases following covid-19 infection have been widely reported.Case report: A 15-year-old type 1 diabetes female patient treated with detemir and glulisine was diagnosed with EIAS based on major glycemic instability and an elevated anti exogenous insulin autoantibody titer of 40 IU (NV...

ea0090p197 | Reproductive and Developmental Endocrinology | ECE2023

Polycystic ovary syndrome phenotype and therapeutic outcomes

Elleuch Mouna , Frikha Hamdi , Ben Salah Dhoha , Triki Molka , Ayadi Younes , Mnif Fatma , Mnif Mouna , Rekik Majdoub Nabila , Charfi Nadia , Haj Kacem Akid Faten , Abid Mohamed

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting women of reproductive age. PCOS has two phenotypes, obese and lean, the latter being a much less common presentation of the syndrome.Aim: Compare PCOS outcomes in patients with obese PCOS and patients with lean PCOS.Methods: A retrospective, single-center, descriptive and comparative study including patients with PCOS followed at the endocrinology d...

ea0090p203 | Reproductive and Developmental Endocrinology | ECE2023

Predictive factors of infertility among patients with polycystic ovary syndrome

Elleuch Mouna , Frikha Hamdi , Triki Molka , Ben Salah Dhoha , Souleima Trigui , Charfi Nadia , Mnif Mouna , Mnif Fatma , Rekik Majdoub Nabila , Haj Kacem Akid Faten , Abid Mohamed

Introduction: Polycystic ovary syndrome (PCOS) is occurring in approximately one in seven women. Infertility is a major issue in PCOS. Recognizing patients with higher risk of infertility is still a matter of debate.Aim: Study the predictive factors of female infertility in patients with PCOSMethods: A retrospective, single-center, comparative and analytical study including patients with PCOS followed at the endocrinology departmen...

ea0090p466 | Reproductive and Developmental Endocrinology | ECE2023

Hyperprolactinemia in Turner syndrome

Haj Kacem Akid Faten , Trimeche Oumeyma , Mnif Mouna , Hamdi Frikha , Ben Salah Dhoha , Elleuch Mouna , Fatma Mnif , Charfi Nadia , Rekik Majdoub Nabila , Abid Mohamed

Introduction: Hyperprolactinemia is a relatively frequent finding. A wide range of conditions can be responsible of this biochemical abnormality. Herein we report a rather rare etiology of hyperprolactinemia which is Turner syndrome (TS).Methods: Aiming to determine the frequency of hyperprolactinemia in patients with TS, we enrolled a retrospective descriptive study in the department of Endocrinology at the Hedi Chaker Hospital. We included patients who...

ea0090ep67 | Adrenal and Cardiovascular Endocrinology | ECE2023

Effect of glucocorticoid replacement dose on bone mineral density in patients with Addison disease: A cross-sectional Tunisian-based study

Boujelben Khouloud , Salah Dhoha Ben , Frikha Hamdi , Elleuch Mouna , Mnif Mouna , Mnif Fatma , Charfi Nadia , Majdoub Nabila Rekik , Kacem Akid Faten Haj , Abid Mohamed

Introduction: Addison disease (AD) is associated with high risk of decreased bone mineral density (BMD) and osteoporosis. Causes are complex, including lifelong glucocorticoid replacement therapy. Several studies have pointed a significant relationship between glucocorticoid dose and low BMD in patients with AD. The aim of our study is to assess the impact of glucocorticoid replacement dose on BMD among Tunisian patients with AD.Patients and Methods: We ...

ea0090ep80 | Adrenal and Cardiovascular Endocrinology | ECE2023

Impact of glucocorticoid replacement therapy on anthropometric parameters in patients with Addison disease

Boujelben Khouloud , Salah Dhoha Ben , Frikha Hamdi , Elleuch Mouna , Charfi Nadia , Mnif Fatma , Mnif Mouna , Majdoub Nabila Rekik , Kacem Akid Faten Haj , Abid Mohamed

Introduction: Inappropriate glucocorticoid replacement therapy results in higher mortality rates in patients with Addison disease (AD), predominantly due to higher prevalence of cardiovascular diseases, disturbed glycometabolic state and altered anthropometric parameters. The aim of this study was to assess the impact of life-long corticosteroid exposure on anthropometric parameters in patients with AD.Patients and Methods: This Tunisian cross-sectional ...